Hearing Loss and Brain Health: What You Need to Know
About one in three Americans over 60 experiences hearing loss — and the risk only grows with age. Changes in the hearing nerve, blood flow,
August 21, 2025
Tomorrow’s treatment today.
It Starts With You
Let's Do This Together
Welcome to K2 Medical Research, a privately-owned clinical research facility in the greater Central Florida area. We specialize in conducting multiphasic clinical trials that promote the development of innovative and effective medical treatments while maintaining the safety and privacy of our participants. Here at K2, we are committed to fighting the diseases that plague our loved ones and ourselves. By harnessing the power of advanced clinical research and connecting our patients with the treatments of tomorrow, we can improve the health of our local communities, and by extent, the population of our world.
Get To Know Our
Principal Investigators
Christopher Galloway, MD is a board-certified Family Medicine physician with 20 years of clinical experience. Dr. Galloway joins K2 as an experienced Principal Investigator having participated in over 100 clinical trials over multiple therapeutic areas and specializing in Neurodegenerative trials. Dr. Galloway earned his undergraduate degree from the University of Utah and is a graduate of New York Medical College. He completed his residency at Florida Hospital (now AdventHealth). He is bilingual in English and Spanish.
Christopher Galloway, MDMedical Director & Principal Investigator 
Dr. Meyer is a board-certified Internal Medicine Physician with greater than 20 years private practice experience and recognized by his peers as a premiere physician in Central Florida. Subsequently, he was a core faculty member launching the University of Central Florida College of Medicine Internal Medicine Residency Program. For the past several years, Dr. Meyer has focused on clinical research as a Principal Investigator, participating in over 60 Phase I-III clinical trials addressing Neurodegenerative Diseases, NASH, Pain, IBD, Vaccines and multiple other therapeutic areas.
Robert Meyer, MD, FACP, CPIPrincipal Investigator 
Christopher Galloway, MD is a board-certified Family Medicine physician with 20 years of clinical experience. Dr. Galloway joins K2 as an experienced Principal Investigator having participated in over 100 clinical trials over multiple therapeutic areas and specializing in Neurodegenerative trials. Dr. Galloway earned his undergraduate degree from the University of Utah and is a graduate of New York Medical College. He completed his residency at Florida Hospital (now AdventHealth). He is bilingual in English and Spanish.
Christopher Galloway, MDMedical Director & Principal Investigator
Dr. Meyer is a board-certified Internal Medicine Physician with greater than 20 years private practice experience and recognized by his peers as a premiere physician in Central Florida. Subsequently, he was a core faculty member launching the University of Central Florida College of Medicine Internal Medicine Residency Program. For the past several years, Dr. Meyer has focused on clinical research as a Principal Investigator, participating in over 60 Phase I-III clinical trials addressing Neurodegenerative Diseases, NASH, Pain, IBD, Vaccines and multiple other therapeutic areas.
Robert Meyer, MD, FACP, CPIPrincipal Investigator
K2 Medical Research - WINTER GARDEN
- 321-500-5252
- 17309 Pagonia Road, Clermont, FL 34711
- 9 A.M. - 5 P.M. Monday - Thursday | Closed on Friday
- Send Message
Years of Experience
5,000+ Trials Completed
We provide an extensive list of open studies, please contact our offices to participate.
70+ Years of Experience
A team of highly trained doctors and staff to provide you with the best care.
100% Patient Satisfaction
Find a clinical study that's right for you. We are ready to answer any questions you might have.
Connecting Research
High-Quality Research Network that spans from the North Pacific to the Atlantic Oceans.
Dedicated to Diversity and Inclusion
Over 20K Participants
Multiculturalism and inclusion are important concepts here at K2. We understand the significance of representation of all populations in clinical research and are aware of the current lack of diversity in trial participants. We endeavor to change this. We reject a set-it and forget-it mentality when it comes to equity and justice; instead, we aim to use these ideas as living, working concepts that inform our daily interactions with one another, with patients and with the community at large. Find out more about what we are doing to promote diversity in our clinical trials.
Clinical Research as a Care Option
Clinical Research as a Care Option (CRAACO) is a concept that is revolutionizing health care as we know it. Considering the use of clinical trials as a tool to supplement and/or replace conventional healthcare is a radical notion, but one that stands to benefit patients, physicians, and the research community as a whole. Some of these benefits include faster drug development, and for patients, a more cost-effective approach with better treatment outcomes. Here at K2 Medical Research, we are fully onboard and are collaborating with local practices to help make this innovative idea a reality for our patients. While traditional healthcare presents many well-known challenges to patients seeking treatment, participating in a clinical research trial offers many practical solutions. By participating in a research study with K2, participants can expect to:
- Receive an unsurpassed standard of care with our experienced physicians.
- Be proactive in their own health.
- Receive innovative treatments not yet available at in-patient healthcare offices.
- Participate in improving the health of future generations.
- Be compensated for time and travel.
Current Studies
Technology is ever-changing and constantly evolving. If you are in search of professionals who will attend to your needs, you can’t go wrong with K2 Medical. Contact our clinic at your earliest convenience to enroll in a clinical trial.
Liver Disease
Latest research and new treatments for liver disease such as Non-alcoholic Steatohepatitis (NASH) and Non-alcoholic fatty liver disease (NAFLD).
Diseases of Nervous System
Research aimed to further understand and treat neurodegenerative diseases such as Alzheimer’s and Parkinson’s Disease.
Pain Psychiatric Disease
Research and treatment options of depressive disorders in the chronic pain patient such as depression and anxiety.
Cardiovascular
Studies range from genetic and molecular studies of the mechanisms of cardiovascular disease to studies of vascular properties, lifestyle interventions, and responsiveness to preventive pharmacotherapy.
Diseases of the Endocrine System
In the United States, the most common endocrine disease is diabetes. There are many others such as Addison’s Disease, Cushing’s Syndrome, Graves’ Disease and Hashimoto’s Thyroiditis to consider clinical trial participation.
Rheumatology and Autoimmune Disorders
Autoimmune rheumatic diseases (ARDs) are a diverse group of conditions that primarily affect the joints, bones, muscle, and connective tissue such as Rheumatoid Arthritis (RA).
Gastrointestinal System
Digestive diseases research for disorders of the digestive tract, which is sometimes called the gastrointestinal (GI) tract such as Gastroesophageal Reflux Disease (GERD), Crohn's Disease Ulcerative Colitis (UC). Irritable Bowel Syndrome (IBS) and Diverticulitis.
Diagnostics
Clinical trials that are conducted to find better tests or procedures for diagnosing a particular disease or condition.
Biomarkers
Innovative translational research uses biomarkers to accelerate or aid in diagnosis or monitoring and provide insight into “personalized” medicine. A biomarker is a quantifiable biological parameter (such as blood pressure, heart rate, blood and genetic test, and x-rays) that are measured and evaluated over time as an indicator of normal biological, pathogenic, or pharmacologic responses to a therapeutic intervention.
Food & Nutrition
Nutrition studies the relationship between foods and its effect on an individual's health. Nutrition considers topics such as obesity, malnutrition, food insecurity and nutritional deficiencies.
COVID-19
Research discovering immunity and treatments for Covid-19
"The staff is wonderful, professional and knowledgeable. They provide you with the best service when possible! Whenever I had a question, they were ready to answer. Quick responses and follow ups, and always gives the best advice. "
Study Participant, August 2021
Sponsorships
Help us, help you meet your drug development goals.
Still curious? Read the latest news and press releases about our office.
5 Highlights from the Largest Alzheimer’s Research Conference
Last week, over 7,000 Alzheimer’s and dementia researchers from around the globe gathered in Toronto for the Alzheimer’s Association International Conference. The new research they
August 5, 2025
3 People on What It’s Like to Be Diagnosed With Alzheimer’s
An Alzheimer’s diagnosis is life-changing. While there’s still no cure to stop the disease’s progression, many people find strength and direction by hearing how others
July 22, 2025
Tomorrow’s treatment today.
